Home » Watson Sells Rugby OTC Product Trademark and Assets to Harvard Drug
Watson Sells Rugby OTC Product Trademark and Assets to Harvard Drug
Watson Pharmaceuticals has sold its Rugby OTC pharmaceutical Product Trademark and Assets to The Harvard Drug Group for nearly $117 million.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May